Understanding and improving treatment for severe pneumonia
Successful Clinical Response In Pneumonia Therapy (SCRIPT) Systems Biology Center
This study is looking at how severe pneumonia, especially from viruses like SARS-CoV-2, affects patients, and it aims to find better ways to predict how well different treatments will work for them, so they can get the best care possible.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11014071 on NIH RePORTER |
What this research studies
This research focuses on pneumonia, particularly severe cases caused by pathogens like SARS-CoV-2. It utilizes advanced techniques such as bronchoalveolar lavage and blood sampling, combined with multi-omics technologies, to analyze the biological responses of patients. By studying the interactions between the host, pathogens, and microbiome, the research aims to develop predictive models that can identify how patients will respond to pneumonia treatment over time. This approach seeks to enhance clinical decision-making and improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with severe community-acquired pneumonia or hospital-acquired pneumonia.
Not a fit: Patients with mild pneumonia or those not requiring hospitalization may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for severe pneumonia, potentially reducing morbidity and mortality rates.
How similar studies have performed: Previous research has shown promise in using multi-omics approaches to understand pneumonia, indicating potential for success in this novel application.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Wunderink, Richard G — Northwestern University at Chicago
- Study coordinator: Wunderink, Richard G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.